 7. Patient who has received radiotherapy within less than or equal to 4 weeks or limited field radiation for palliation within less than or equal to 2 weeks prior to starting study drug, and who has not recovered to grade 1 or better from related side effects of such therapy exceptions include alopecia andor in whom greater than or equal to 30 of the bone marrow was irradiated. 